Nicardipine Terminated Phase 2 Trials for Cerebral Vasospasm Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01810302Safety Study of Nicardipine to Treat Cerebral Vasospasm